Back to list

Hippocratic AI

Healthcare-specific foundation model and AI agent platform delivering low-acuity clinical conversations for hospitals and payers
Healthcare 📍 Palo Alto, CA Founded 2023
Current Valuation
$3.5B
as of 2025-Q1
UNICORN

IPO Outlookprivate

Is Hippocratic AI going public?
No. Hippocratic AI has no imminent IPO plans on record. It is still private.
What is Hippocratic AI's valuation in 2026?
Hippocratic AI is valued at $3.5B as of 2025-Q1, set by its Series B ($141M, Jan 2025). That is the last confirmed mark, not a live price — private shares do not trade continuously.
Has Hippocratic AI filed an S-1?
No public S-1 is on file for Hippocratic AI.
Who are Hippocratic AI's investors?
Hippocratic AI's investors include Kleiner Perkins, Andreessen Horowitz, Premji Invest, General Catalyst, NVIDIA, Universal Health Services.
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.
Hippocratic AI builds a healthcare-specific foundation model (Polaris) for low-acuity patient-facing conversations like care coordination, dietitian consultations, and medication reminders. Founded by Munjal Shah (serial entrepreneur, ex-Like.com → Google acquisition). Tested with 5,500+ licensed nurses for safety validation. Partnered with NVIDIA on optimized inference. Customers include WellSpan Health, Cincinnati Children's, and Universal Health Services.

Company Profile

CEO
Munjal Shah
Founded
2023
HQ
Palo Alto, CA
Employees
~250
Total Raised
$278M
Growth
Early commercial (health system pilots)
Last Round
Series B — $141M (Jan 2025) · Lead: Kleiner Perkins
IPO Status
no imminent plans

Fundraising Status

Series B · $141M · 1y 7mo ago
no imminent plansTotal raised $278M

Secondary Market

Implied price / share
$26.33
Last round price / share
$26.33
vs last round
0.0%
Last round price vs secondary price
Last round vs current secondary price per share$26.33Last round$26.33Current
Secondary price return by period
Secondary market period returns3-month0.0%6-month+427%1-year+953%All-time+953%
Implied per-share price from private secondary transactions, as of Jun 2026. This is a point estimate, not a quote — the feed carries no bid, ask or spread, and a secondary print is evidence of what someone paid on that date rather than a live market. Compare across every tracked name →

Latest Funding Round

RoundAmountDateLead InvestorPost-Money
Series B$141MJan 2025Kleiner Perkins

Vertical Intelligence — AI / ML

Open models
0
Downloads (30d)
0
across all models
Followers
15
Attributed to Hugging Face organization "Hippocratic AI" as of 2026-08-19. Open-weights footprint only — closed-model usage is not publicly measurable. Verify on Hugging Face ↗

Talent Signal

Hiring trend
First snapshot
trend accrues with monthly sweeps
Open roles
5
via careers page
Product-build share
100%
engineering, research, product, design
Trajectory
steady
heavy product build — 100% of open roles are product-building functions (engineering/research/product) — 4 of 5 open roles are research.
Actively hiring with no tracked executive churn.
Open roles by month
Open roles by month5Aug '26
Open roles by function
Open roles by functionResearch4Clinical & Science1
product-building   go-to-market / G&A
LLM ResearchClinical ResearchNurse Grants[LLM Research](https://hippocraticai.com/llm-research/)[Clinical Research](https://hippocraticai.com/clinical-research-2/)
Counted from Hippocratic AI's live job board as of 2026-08-17; role functions classified from posting titles. Open-role counts are an activity signal, not headcount. Refreshed monthly.

Founders & Key People

Munjal Shah

Investors

Kleiner Perkins · Andreessen Horowitz · Premji Invest · General Catalyst · NVIDIA · Universal Health Services

Products

  • Hippocratic Healthcare LLM
  • Polaris (constellation of healthcare agents)
  • Pulse (medical history-taking agent)

Competitors

Suki AI · Abridge · Ambience Healthcare · DeepScribe · Glass Health
HealthcareAIClinical AIHealthcare LLM
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2025-Q1. Refreshed quarterly.